EUVIMEDEUVIMED entdecken
Crossref

Identification of an m6A Natural Inhibitor, Lobeline, That Reverses Lenvatinib Resistance in Hepatocellular Tumors

Lei Zhao, Heyao Ma, Yuhui Jiang, Yingying Li, Li Qiao, Yu Chen, Xiaowen Jiang, Lihui Wang iD, Shu Wang, Xinyu Fan

Journal of Natural Products · 2024

DOI: 10.1021/acs.jnatprod.4c00406 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Natural Products, 2024. Verfasst von Lei Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Drug Resistance, Neoplasm, Liver Neoplasms, Phenylurea Compounds. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: China International Medical Foundation, People's Government of Liaoning Province, Natural Science Foundation of Shenyang Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularDrug Resistance, NeoplasmLiver NeoplasmsPhenylurea CompoundsQuinolinesAnimalsHumansMiceAdenosineAntineoplastic AgentsBiological ProductsCell Line, TumorMolecular StructureLobeline

Substanzen

AdenosineAntineoplastic AgentsBiological ProductslenvatinibN-methyladenosinePhenylurea CompoundsQuinolinesLobeline

Autor:innen und Institutionen

  • Department of Hepatobiliary and Pancreatic Surgery, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China.
  • Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang, Liaoning 110122, China.
  • Department of Pharmacology, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Department of Analysis and Pharmacology of Traditional Chinese Medicine, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • Department of Nuclear Medicine, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China.
  • Department of Pharmacy, Shengjing Hospital of China Medical University, Shenyang, Liaoning 110004, China.

ORCID-Profile: Lihui Wang

Förderung

  • China International Medical Foundation
  • People's Government of Liaoning Province
  • Natural Science Foundation of Shenyang Municipality
  • Shengjing Hospital

Zitieren

APA

Zhao, L., Ma, H., Jiang, Y., Li, Y., Qiao, L., Chen, Y., Jiang, X., Wang, L., Wang, S., & Fan, X. (2024). Identification of an m6A Natural Inhibitor, Lobeline, That Reverses Lenvatinib Resistance in Hepatocellular Tumors. Journal of Natural Products. https://doi.org/10.1021/acs.jnatprod.4c00406

Vancouver

Zhao L, Ma H, Jiang Y, Li Y, Qiao L, Chen Y, et al. Identification of an m6A Natural Inhibitor, Lobeline, That Reverses Lenvatinib Resistance in Hepatocellular Tumors. Journal of Natural Products. 2024. doi:10.1021/acs.jnatprod.4c00406

BibTeX
@article{Zhao2024,
  author = {Zhao, Lei and Ma, Heyao and Jiang, Yuhui and Li, Yingying and Qiao, Li and Chen, Yu and Jiang, Xiaowen and Wang, Lihui and Wang, Shu and Fan, Xinyu},
  title = {Identification of an m6A Natural Inhibitor, Lobeline, That Reverses Lenvatinib Resistance in Hepatocellular Tumors},
  journal = {Journal of Natural Products},
  year = {2024},
  doi = {10.1021/acs.jnatprod.4c00406}
}
Kostenlos starten →